Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9725970 | 1.00 | CA1 (0.41) | CA1CA2CA12CA9NPC1 | |
| SCHEMBL199270 | 1.00 | CA1 (0.41) | CA1CA2CA12CA9NPC1 | |
| SCHEMBL198177 | 1.00 | CA1 (0.41) | CA1CA2CA12CA9NPC1 | |
| SCHEMBL6100779 | 1.00 | CA1 (0.41) | CA1CA2CA12CA9NPC1 | |
| SCHEMBL6333537 | 1.00 | CA1 (0.41) | CA1CA2CA12CA9NPC1 | |
| SCHEMBL10775019 | 1.00 | CA1 (0.41) | CA1CA2CA12CA9NPC1 | |
| SCHEMBL23581147 | 0.96 | CA1 (0.39) | CA1CA2CA12CA9NPC1 | |
| SCHEMBL106379 | 0.96 | CA1 (0.39) | CA1CA2CA12CA9NPC1 | |
| SCHEMBL108021 | 0.96 | CA1 (0.39) | CA1CA2CA12CA9NPC1 | |
| SCHEMBL11615689 | 0.96 | CA1 (0.39) | CA1CA2CA12CA9NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624318-B2 | Cleaning agent composition and cleaning method | NISSAN CHEMICAL CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| US-20260071152-A1 | CLEANING METHOD | NISSAN CHEMICAL CORPORATION (JP) | 2026-03-12 | — | — | US | disclosed |
| US-20250376645-A1 | METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE | NISSAN CHEMICAL CORPORATION (JP) | 2025-12-11 | — | — | US | disclosed |
| CN-113439324-B | Cleaning agent composition and cleaning method | 日产化学株式会社 | 2025-03-04 | — | — | CN | disclosed |
| CN-108368016-B | Process for producing cyclopentyl alkyl ether compound | 日本瑞翁株式会社 | 2023-09-26 | — | — | CN | disclosed |
| US-11732214-B2 | Cleaning agent composition comprising an alkylamide solvent and a fluorine-containing quaternary ammonium salt | NISSAN CHEMICAL CORPORATION (JP) | 2023-08-22 | — | — | US | disclosed |
| US-20230129238-A1 | CLEANING AGENT COMPOSITION AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE | NISSAN CHEMICAL CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| EP-4130217-A1 | CLEANING AGENT COMPOSITION AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE | Nissan Chemical Corporation (JP) | 2023-02-08 | — | — | EP | disclosed |
| US-20230002701-A1 | CLEANING AGENT COMPOSITION AND CLEANING METHOD | NISSAN CHEMICAL CORPORATION (JP) | 2023-01-05 | — | — | US | disclosed |
| CN-115362246-A | Cleaning agent composition and method for producing processed semiconductor substrate | 日产化学株式会社 | 2022-11-18 | — | — | CN | disclosed |
| US-20120129855-A1 | PHTHALAZINONE DERIVATIVES | MENEAR KEITH ALLAN (GB) | 2012-05-24 | — | — | US | disclosed |
| US-7282316-B2 | Sulfonyldiazomethane compounds, photoacid generator, resist materials and patterning using the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-10-16 | — | — | US | disclosed |
| US-20050048395-A1 | Novel sulfonyldiazomethane compounds, photoacid generator, resist materials and patterning process using the same | SHIN-ETSU CHEMICAL CO., LTD. | 2005-03-03 | — | — | US | disclosed |
| US-5723250-A | Process for image formation using liquid developer | FUJI XEROX CO., LTD. (JP) | 1998-03-03 | — | — | US | disclosed |
| US-5622804-A | COMPOSITION INCLUDING CARRIER COMPRISING ETHER COMPOUND, CHARGE DIRECTOR, DISPERSED TONER PARTICLES COMPRISING INSOLUBLE THERMOPLASTIC RESIN, COLORANT, CHARGE CONTROL AGENT | FUJI XEROX CO., LTD. (JP) | 1997-04-22 | — | — | US | disclosed |
| US-5529874-A | ETHER CARRIER LIQUID AND TONER PARTICLES DISPERSED THEREIN; SUITABLE FOR HIGH SPEED COPYING | FUJI XEROX CO., LTD. (JP) | 1996-06-25 | — | — | US | disclosed |
| US-RE32896-E | GROUP 1B OR 4B METAL OXIDES AS CATALYSTS | ETHYL CORPORATION (US) | 1989-03-28 | — | — | US | disclosed |
| US-4721810-A | METAL OXIDE CATALYSTS | ETHYL CORPORATION (US) | 1988-01-26 | — | — | US | disclosed |
| EP-0240631-A1 | Alkylation of amines and amides | ETHYL CORPORATION (US) | 1987-10-14 | — | — | EP | disclosed |
| US-4626592-A | WITH A CYCLIC ETHER AND B-SUBGROUP METAL OXIDE ALKYLATION CATALYST | ETHYL CORPORATION (US) | 1986-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071152-A1 | CLEANING METHOD | FGB, CDH1, RNF168 | CA1 3126/4885CA2 4688/4885CA12 3214/4885 |
| US-20120129855-A1 | PHTHALAZINONE DERIVATIVES | CBR1, CBR3, SDHA | CA1 3734/4885CA2 2814/4885CA12 2512/4885 |
| US-12624318-B2 | Cleaning agent composition and cleaning method | DNMT1, TLN1, TET2 | CA1 958/4885CA2 2383/4885CA12 1945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.